Introduction to Achieving Durable Responses In Advanced Melanoma
Let's dive into the details surrounding Achieving Durable Responses In Advanced Melanoma. Panelists Robert H.I. Andtbacka, MD, CM; Georgina Long, MD; and Antoni Ribas, MD, PhD, provide insight on the potential for ...
Achieving Durable Responses In Advanced Melanoma Comprehensive Overview
Dr Mario Sznol presents long-term follow-up results, at the 2013 ASCO Annual meeting, from an expanded phase I study which ... Michael A. Postow, MD, and Michael B. Atkins, MD, share their experiences with using immunotherapy versus targeted therapy in ... Michael A. Postow, MD, and Michael B. Atkins, MD, share their experiences with using immunotherapy versus targeted therapy in ...
Daniel Wang, M.D., Associate Professor of Internal Medicine in the Division of Hematology and Oncology and Co-Leader of the ...
Summary & Highlights for Achieving Durable Responses In Advanced Melanoma
- Presentation given by Lance Cowey, MD, as part of the AIM at
- Antoni Ribas, MD, PhD, the director of the Tumor Immunology Program Area at UCLA's Jonsson Comprehensive Cancer Center, ...
- Professor Kevin Harrington speaks to Claire Hastings about the Phase III trial of T-VEC – a viral immunotherapy that's showing ...
- Panelists discuss the utilization of surgery following the administration of targeted and immuno-therapies as treatments for ...
- Presentation given by Lance Cowey, MD, at Baylor Charles A. Sammons Cancer Center, as part of AIM at
That wraps up our extensive overview of Achieving Durable Responses In Advanced Melanoma.
